Cytotoxic T lymphocyte antigen 4 gene polymorphism associated with ST-segment elevation acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation Journal

• Publication date

  2007-07-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.71.1213PMID 17652883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.

  2007cited by this paper
• Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty.

  2007cited by this paper
• Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography.

  2006cited by this paper
• N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

  2006cited by this paper
• Strong correlation between serum levels of inflammatory mediators and their distribution in infarct-related coronary artery.

  2006cited by this paper
• Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein

  2005cited by this paper
• Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.

  2005cited by this paper
• Tumor Necrosis Factor- (cid:1) Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial Infarction The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) Study

  2005cited by this paper
• Inflammation and Atherosclerosis

  2004cited by this paper
• Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal.

  2004cited by this paper
• Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.

  2004cited by this paper
• Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes

  2004cited by this paper
• T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

  2003cited by this paper
• A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death: Association With Different Pathologies

  2002cited by this paper
• Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

  2001cited by this paper
• Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants.

  2001cited by this paper
• Polymorphism in the Promoter and Exon 1 of the Cytotoxic T Lymphocyte Antigen-4 Gene Associated with Autoimmune Thyroid Disease in Koreans

  2000cited by this paper
• Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro.

  2000cited by this paper
• Immune inhibitory receptors.

  2000cited by this paper
• Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy

  2000cited by this paper
• Evidence for Antigen-Driven T-Cell Response in Unstable Angina

  2000cited by this paper
• Stress pathways and heart failure.

  1999cited by this paper
• Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.

  1999cited by this paper
• Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling.

  1998cited by this paper
• CTLA4 Gene Polymorphism Confers Susceptibility to Graves' Disease in Japanese

  1997cited by this paper
• Molecular Determinants of Atherosclerotic Plaque Vulnerability a

  1997cited by this paper
• The unstable atheroma.

  1997cited by this paper
• Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.

  1997cited by this paper
• Costimulation and autoimmunity.

  1996cited by this paper
• The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses

  1996cited by this paper
• Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

  1995cited by this paper
• Coronary plaque disruption.

  1995cited by this paper
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

  1995cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper
• Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

  1994cited by this paper
• CTLA-4 can function as a negative regulator of T cell activation.

  1994cited by this paper
• Immune mechanisms of cardiac disease.

  1994cited by this paper
• Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque

  1986cited by this paper
• Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.

  1986cited by this paper
• Post-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin).

  1985cited by this paper

• Safety and efficacy of intracoronary artery administration of human bone marrow-derived mesenchymal stem cells in STEMI of Lee-Sung pigs—A preclinical study for supporting the feasibility of the OmniMSC-AMI phase I clinical trial

  2023cites this paper
• Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients.

  2022cites this paper
• Intra-Coronary Administration of Tacrolimus Improves Myocardial Perfusion and Left Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction (COAT-STEMI) Undergoing Primary Percutaneous Coronary Intervention.

  2021cites this paper
• Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer

  2020cites this paper
• Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects

  2018cites this paper
• Intra-Coronary Administration of Tacrolimus Prior to First-BalloonInflation Attenuates Infarct Size and Improves Left Ventricular Function in Patients with ST-segment Elevation Myocardial Infarction (COAT-STEMI) Undergoing Primary Coronary Intervention

  2014cites this paper
• White blood cell transcriptome correlates with renal function in acute heart failure.

  2012cites this paper
• Serum level and prognostic value of neopterin in patients after ischemic stroke.

  2012cites this paper
• Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction.

  2011cites this paper
• Prognostic Value of Circulating Dead Monocytes in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2010cites this paper
• Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis.

  2009cites this paper
• Progression of non-culprit coronary artery atherosclerosis after acute myocardial infarction in comparison with stable angina pectoris.

  2008cites this paper